Dow Up 0.51% Nasdaq Up 0.24%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM
0.67 Nov 21, 4:00PM EST
Prev Close:0.67
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:2.00
Beta:2.16
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.39 - 4.91
Volume:0
Avg Vol (3m):108,946
Market Cap:8.49M
P/E (ttm):N/A
EPS (ttm):-1.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECTE

Comparison

Symbol% ChgMkt Cap
ECTE 0.00%8.49M
ABT65.97B
DXCM3.86B
MDT71.18B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):410.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.19
Quarterly EPS Est (Dec-14) :-0.32
Mean Recommendation*:5.0
PEG Ratio (5 yr expected):-0.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback